Banco De Sabadell, S.A Grifols Sa Transaction History

Banco De Sabadell, S.A

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$19.57 - $23.52 $5.87 Million - $7.06 Million	-300,000 Closed	0 $0
Q3 2019 Nov 15, 2019	SELL	$19.85 - $22.76 $992,500 - $1.14 Million	-50,000 Reduced 14.29%	300,000 $6.05 Million
Q3 2018 Nov 16, 2018	BUY	$19.97 - $21.96 $6.99 Million - $7.69 Million	350,000 New	350,000 $7.47 Million

173

145M

132K

82.6K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $4.97B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Banco De Sabadell, S.A, based on Form 13F filings with the SEC.

Stay updated on Banco De Sabadell, S.A with notifications on news.